PA
MSGE icon

PharVision Advisers’s Madison Square Garden MSGE Stock Holding History

PharVision Advisers’s Portfolio MSGE Stock Details MSGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,536
Closed -$298K – 444
2025
Q4 		$298K Buy
+5,536
New +$266K 0.15% 276

Other funds holding MSGE

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DC
Dendur Capital New York $1.9B AUM 46.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

PharVision Advisers's MSGE Position: Q1 2026 in Review

PharVision Advisers sold out of Madison Square Garden (MSGE) in Q1 2026, closing a stake of 5,536 shares — an estimated $298K sold.

PharVision Advisers first reported a position in MSGE in Q4 2025 and held it in 1 quarter. The position peaked at $298K in Q4 2025. 243 funds tracked by Wall St. Rank hold MSGE as of Q1 2026.

  • PharVision Advisers reported no remaining Madison Square Garden position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 5,536 Madison Square Garden shares in Q1 2026, an estimated $298K.
  • PharVision Advisers first reported a position in Madison Square Garden in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Madison Square Garden position peaked at $298K in Q4 2025.
  • 243 funds tracked by Wall St. Rank held Madison Square Garden as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.